The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
CB1 Cannabinoid Receptors and their Associated Proteins
Open accessAbstract
CB1 receptors are G-protein coupled receptors (GPCRs) abundant in neurons, in which they modulate neurotransmission. The CB(1) receptor influence on memory and learning is well recognized, and disease states associated with CB(1) receptors are observed in addiction disorders, motor dysfunction, schizophrenia, and in bipolar, depression, and anxiety disorders. Beyond the brain, CB(1) receptors also function in liver and adipose tissues, vascular as well as cardiac tissue, reproductive tissues and bone. Signal transduction by CB(1) receptors occurs through interaction with Gi/o proteins to inhibit adenylyl cyclase, activate mitogen-activated protein kinases (MAPK), inhibit voltage-gated Ca(2+) channels, activate K(+) currents (K(ir)), and influence Nitric Oxide (NO) signaling. CB(1) receptors are observed in internal organelles as well as plasma membrane. beta-Arrestins, adaptor protein AP-3, and G-protein receptor-associated sorting protein 1 (GASP1) modulate cellular trafficking. Cannabinoid Receptor Interacting Protein1a (CRIP1a) is an accessory protein whose function has not been delineated. Factor Associated with Neutral sphingomyelinase (FAN) regulates ceramide signaling. Such diversity in cellular signaling and modulation by interacting proteins suggests that agonists and allosteric modulators could be developed to specifically regulate unique, cell type-specific responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationCoupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins
Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80810-7 · Cited by 1,050
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
Galve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Xiao, B., Tu, J. C., Petralia, R. S., Yuan, J. P., Doan, A., Breder, C. D., Ruggiero, A., Lanahan, A. A., Wenthold, R. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80588-7 · Cited by 647
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Involvement of the endocannabinoid system in drug addiction
Maldonado, R., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 580
Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 543
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
Induction of Nitric Oxide Synthase in Glial Cells
Simmons, M. L., & Murphy, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08328.x · Cited by 491
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 461
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_2 · Cited by 446
Self-citationPalmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules
Resh, M. D. (2006) · Science's STKE · doi:10.1126/stke.3592006re14 · Cited by 414
Shiraishi‐Yamaguchi, Y., & Furuichi, T. (2007) · Genome biology · doi:10.1186/gb-2007-8-2-206 · Cited by 371
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 362
Functional CB1 cannabinoid receptors in human vascular endothelial cells
Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460835 · Cited by 333
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.-C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J., & Girault, J.-A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02371.2003 · Cited by 331
The cannabinoid receptor: biochemical, anatomical and behavioral characterization
Howlett, A. C., Bidaut-Russell, M., Devane, W. A., Melvin, L. S., Johnson, M. R., & Herkenham, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90124-s · Cited by 311
Self-citationGebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308
Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291
A Function for the AP3 Coat Complex in Synaptic Vesicle Formation from Endosomes
Faúndez, V., Horng, J.-T., & Kelly, R. B. (1998) · Cell · doi:10.1016/s0092-8674(00)81170-8 · Cited by 289
Hart, S., Fischer, O. M., & Ullrich, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3720 · Cited by 288
Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein
Bermak, J. C., Li, M., Bullock, C., & Zhou, Q.-Y. (2001) · Nature Cell Biology · doi:10.1038/35074561 · Cited by 281
Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells
Sánchez, C., Galve-Roperh, I., Canova, C., Brachet, P., & Guzmán, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01085-0 · Cited by 280
Caulfield, M. P., & Brown, D. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14321.x · Cited by 278
Moreira, F. A., Grieb, M., & Lutz, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.003 · Cited by 272
Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.004 · Cited by 271
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., & Mackie, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03773.1999 · Cited by 261
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259
Rueda, D., Navarro, B., Martı́nez-Serrano, A., Guzmán, M., & Galve-Roperh, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206590200 · Cited by 254
Ludányi, A., Erőss, L., Czirják, S., Vajda, J., Halász, P., Watanabe, M., Palkovits, M., Maglóczky, Z., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4465-07.2008 · Cited by 243
Constitutive Endocytic Cycle of the CB1 Cannabinoid Receptor
Leterrier, C., Bonnard, D., Carrel, D., Rossier, J., & Lenkei, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403990200 · Cited by 236
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Bonhaus, D. W., Chang, L. K., Kwan, J., & Martin, G. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37876-0 · Cited by 223
The endocannabinoid system as a target for the treatment of motor dysfunction
Fernández‐Ruiz, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00088.x · Cited by 214
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213 · cited 1×
“Other central nervous system diseases that might involve a CB1 receptor component include schizophrenia, and bipolar, depression, and anxiety disorders [17,18].”
BackgroundHomer 1b Regulates the Trafficking of Group I Metabotropic Glutamate Receptors
Roche, K. W., Tu, J. C., Petralia, R. S., Xiao, B., Wenthold, R. J., & Worley, P. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25953 · Cited by 212
Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission
Hampson, A. J., Bornheim, L. M., Scanziani, M., Yost, C. S., Gray, A. T., Hansen, B. M., Leonoudakis, D. J., & Bickler, P. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020671.x · Cited by 208
Leterrier, C., Lainé, J., Darmon, M., Boudin, H., Rossier, J., & Lenkei, Z. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5437-05.2006 · Cited by 201
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve-Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23114-x · Cited by 200
Sánchez, C., Galve-Roperh, I., Rueda, D., & Guzmán, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.834 · Cited by 192
Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190
Guo, J., & Ikeda, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.665 · Cited by 190
Cannabinoids and appetite: food craving and food pleasure
Kirkham, T. C. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782810 · Cited by 189 · cited 1×
“Highly coupled to memory and learning, CB1 receptors play a role in addiction processes that extend from reinforcement of high-fat, sweet food intake [12] to dependence on reinforcing drugs and alcohol [13–15].”
BackgroundMechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor
Galve-Roperh, I., Rueda, D., Gómez del Pulgar, T., Velasco, G., & Guzmán, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1385 · Cited by 185
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19238 · Cited by 185
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13484 · Cited by 184
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
Rameau, G. A., Tukey, D. S., Garcin, E. D., Titcombe, R. F., Misra, C., Khatri, L., Getzoff, E. D., & Ziff, E. B. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4799-06.2007 · Cited by 179
The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_5 · Cited by 177
Homer proteins: implications for neuropsychiatric disorders
Szumlinski, K. K., Kalivas, P. W., & Worley, P. F. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.002 · Cited by 174
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173
Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine signaling
Bergson, C., Levenson, R., Goldman-Rakic, P. S., & Lidow, M. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00232-3 · Cited by 164
Guzmán, M., Sánchez, C., & Galve-Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161
Regulation of CB 1 cannabinoid receptor trafficking by the adaptor protein AP‐3
Rozenfeld, R., & Devi, L. A. (2008) · The FASEB Journal · doi:10.1096/fj.07-102731 · Cited by 160
Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D., & Reggio, P. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1274 · Cited by 160
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159 · cited 13×
“CB1 receptors and Gi/o proteins could also regulateERK1/2 activation in PC12 cells via a non-receptor Src or Fyn tyrosine phosphorylation. p38 MAPK was activated by cannabinoid receptor agonists in human vein endothelial cells [101], mouse hippocampal slices[102], and CHO cells heterologously expressing CB1 receptors…”
BackgroundInfluentialCannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampus
Derkinderen, P., Ledent, C., Parmentier, M., & Girault, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00333.x · Cited by 159
Van Gaal, L. F., Scheen, A. J., Rissanen, A. M., Rössner, S., Hanotin, C., & Ziegler, O. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn076 · Cited by 156
Daigle, T. L., Kearn, C. S., & Mackie, K. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.005 · Cited by 155
Rameau, G. A., Chiu, L.-Y., & Ziff, E. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311103200 · Cited by 153
Martini, L., Waldhoer, M., Pusch, M., Kharazia, V., Fong, J. C., Lee, J. H., Freissmuth, C., & Whistler, J. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-7132com · Cited by 152
Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain
Jain, A. K., Ryan, J. R., McMahon, F. G., & Smith, G. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02610.x · Cited by 150
Vásquez, C., & Lewis, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09271.1999 · Cited by 150
Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148
Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
Pan, X., Ikeda, S. R., & Lewis, D. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08786-3 · Cited by 146
Wiring and firing neuronal networks: endocannabinoids take center stage
Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 145
Niehaus, J. L., Liu, Y., Wallis, K. T., Egertová, M., Bhartur, S. G., Mukhopadhyay, S., Shi, S., He, H., Selley, D. E., Howlett, A. C., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039263 · Cited by 144
Self-citationMechanisms of Control of Neuron Survival by the Endocannabinoid System
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 137
D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor
Jarrahian, A., Watts, V. J., & Barker, E. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057620 · Cited by 135
The Endocannabinoid System and Extinction Learning
Lutz, B. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8004-x · Cited by 132
Jordan, J. D., He, J. C., Eungdamrong, N. J., Gomes, I., Ali, W., Nguyen, T., Bivona, T. G., Philips, M. R., Devi, L. A., & Iyengar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411521200 · Cited by 132
Endocannabinoids: Friends and foes of reproduction
Maccarrone, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.07.001 · Cited by 131
He, C., Gomes, I., Nguyen, T., Jayaram, G., Ram, P. T., Devi, L. A., & Iyengar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502812200 · Cited by 129
Davis, M. I., Ronesi, J. A., & Lovinger, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305697200 · Cited by 125
Maneuf, Y. P., & Brotchie, J. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701101 · Cited by 120
Bouaboula, M., Desnoyer, N., Carayon, P., Combes, T., & Casellas, P. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12171-2 · Cited by 115
Blázquez, C., Sánchez, C., Velasco, G., & Guzmán, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041597.x · Cited by 114
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 113
Andersson, M., Usiello, A., Borgkvist, A., Pozzi, L., Dominguez, C. A., Fienberg, A. A., Svenningsson, P., Fredholm, B. B., Borrelli, E., Greengard, P., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1289-05.2005 · Cited by 111
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Zhuang, S.-Y., Bridges, D., Grigorenko, E. V., McCloud, S., Boon, A., Hampson, R. E., & Deadwyler, S. A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.005 · Cited by 109
Daigle, T. L., Kwok, M., & Mackie, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05336.x · Cited by 109
Identification of a novel family of G protein‐coupled receptor associated sorting proteins
Simonin, F., Karcher, P., Boeuf, J., Matifas, A., & Kieffer, B. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02411.x · Cited by 108
A Molecular Basis of Analgesic Tolerance to Cannabinoids
Tappe‐Theodor, A., Agarwal, N., Katona, I., Rubino, T., Martini, L., Swiercz, J. M., Mackie, K., Monyer, H., Parolaro, D., Whistler, J. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5648-06.2007 · Cited by 106
A neutral CB1 receptor antagonist reduces weight gain in rat
Chambers, A. P., Vemuri, K. V., Peng, Y., Wood, J. T., Olszewska, T., Pittman, Q. J., Makriyannis, A., & Sharkey, K. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00663.2007 · Cited by 105
Fimiani, C., Mattocks, D. A. L., Cavani, F., Salzet, M., Deutsch, D. G., Pryor, S. C., Bilfinger, T. V., & Stefano, G. B. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00060-6 · Cited by 104
Sánchez, C., Rueda, D., Ségui, B., Galve‐Roperh, I., Levade, T., & Guzmán, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.955 · Cited by 102
Abadji, V., Lucas-Lenard, J. M., Chin, C., & Kendall, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722032.x · Cited by 101
Mukhopadhyay, S., McIntosh, H. H., Houston, D. B., & Howlett, A. C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26454-3 · Cited by 101
Self-citationRinaldi, M. L., Duigou, A. L., Oustric, D., Barth, F., Bouaboula, M., Carayon, P., Casellas, P., & Fur, G. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37898-x · Cited by 98
Shi, G., Faúndez, V., Roos, J., Dell’Angelica, E. C., & Kelly, R. B. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.4.947 · Cited by 97
Experience with the Synthetic Cannabinoid Nabilone in Chronic Noncancer Pain
Berlach, D. M., Shir, Y., & Ware, M. A. (2006) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00085.x · Cited by 96
ADP Ribosylation Factor 1 Is Required for Synaptic Vesicle Budding in PC12 Cells
Faúndez, V., Horng, J., & Kelly, R. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.505 · Cited by 96
Hillard, C. J., Muthian, S., & Kearn, C. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01253-3 · Cited by 93
Stefano, G. B., Salzet, M., Magazine, H. I., & Bilfinger, T. V. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199806000-00003 · Cited by 93
A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
Ware, M. A. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1132 · Cited by 92
Cannabinoids and ceramide: Two lipids acting hand-by-hand
Velasco, G., Galve‐Roperh, I., Sánchez, C., Blázquez, C., Haro, A., & Guzmán, M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.015 · Cited by 91
Endocannabinoids and the Heart
Hiley, C. R. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318192671d · Cited by 90
Prévot, V., Rialas, C. M., Croix, D., Salzet, M., Dupouy, J., Poulain, P., Beauvillain, J., & Stefano, G. B. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00066-3 · Cited by 89
Hampson, R. E., Mu, J., & Deadwyler, S. A. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.84.5.2356 · Cited by 88
Nie, J., & Lewis, D. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08758.2001 · Cited by 88
McDonald, N. A., Henstridge, C. M., Connolly, C. N., & Irving, A. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029348 · Cited by 87
Effects of cannabinoids on energy metabolism
Guzmán, M., & Sánchez, C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00288-x · Cited by 84
Efficacy in CB1 receptor‐mediated signal transduction
Howlett, A. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705881 · Cited by 80
Self-citationCohen, J. L., Jorizzo, J. L., & Kircik, L. (2007) · PubMed · Cited by 79
Howlett, A. C., Song, C., Berglund, B. A., Wilken, G. H., & Pigg, J. J. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.504 · Cited by 79
Self-citationHe, C., Neves, S. R., Jordan, J. D., & Iyengar, R. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-025 · Cited by 79
Anandamide‐induced mobilization of cytosolic Ca 2+ in endothelial cells
Mombouli, J., Schaeffer, G., Holzmann, S., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702483 · Cited by 78
The Development of Cannabinoid Antagonists
Barth, F., & Rinaldi, M. L. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401143808 · Cited by 77
Biosynthesis and trafficking of seven transmembrane receptor signalling complexes
Dupré, D. J., & Hébert, T. E. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.009 · Cited by 73
Food Intake‐independent Effects of CB1 Antagonism on Glucose and Lipid Metabolism
Cota, D., Sandoval, D. A., Olivieri, M., Prodi, E., D’Alessio, D. A., Woods, S. C., Seeley, R. J., & Obici, S. (2009) · Obesity · doi:10.1038/oby.2009.84 · Cited by 72
Rubino, T., Viganò, D., Premoli, F., Castiglioni, C., Bianchessi, S., Zippel, R., & Parolaro, D. (2006) · Molecular Neurobiology · doi:10.1385/mn:33:3:199 · Cited by 69
Selective and Potent Analgetics Derived from Cannabinoids
Johnson, M. R., Melvin, L. S., ALTHUIS, T. H., Bindra, J. S., Harbert, C. A., Milne, G. M., & Weissman, A. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02605.x · Cited by 66
Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice
Breivogel, C. S., Lambert, J. M., Gerfin, S., Huffman, J. W., & Razdan, R. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328308f1e6 · Cited by 66
The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity
Esposito, G., Ligresti, A., Izzo, A. A., Bisogno, T., Ruvo, M., Rosa, M. D., Marzo, V. D., & Iuvone, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207170200 · Cited by 64
Priller, J., Briley, E. M., Mansouri, J., Devane, W. A., Mackie, K., & Felder, C. C. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10247-2 · Cited by 64
What is the function of neuronal AP‐3?
Danglot, L., & Galli, T. (2007) · Biology of the Cell · doi:10.1042/bc20070029 · Cited by 63
Differential Receptor–G-Protein Coupling Evoked by Dissimilar Cannabinoid Receptor Agonists
Houston, D. B., & Howlett, A. C. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00013-8 · Cited by 62
Self-citationCabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 60
Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms*
Anavi-Goffer, S., Fleischer, D., Hurst, D. P., Lynch, D., Barnett-Norris, J., Shi, S., Lewis, D. L., Mukhopadhyay, S., Howlett, A., Reggio, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703388200 · Cited by 59
Self-citationRamer, R., Weinzierl, U., Schwind, B., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1189 · Cited by 59
Vesiculation and sorting from PC12-derived endosomes in vitro
Lichtenstein, Y., Desnos, C., Faúndez, V., Kelly, R. B., & Clift-O'Grady, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11223 · Cited by 54
The Polarised Life of the Endocannabinoid System in CNS Development
Anavi‐Goffer, S., & Mulder, J. (2009) · ChemBioChem · doi:10.1002/cbic.200800827 · Cited by 51
Jones, J. D., Carney, S. T., Vrana, K. E., Norford, D. C., & Howlett, A. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.027 · Cited by 50
Self-citationCB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells
McIntosh, H. H., Song, C., & Howlett, A. C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00294-5 · Cited by 50
Self-citationPanagis, G., Vlachou, S., & Nomikos, G. G. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030350 · Cited by 49
Nie, J., & Lewis, D. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00335-9 · Cited by 48
CB1 cannabinoid receptor‐mediated neurite remodeling in mouse neuroblastoma N1E‐115 cells
Zhou, D., & Song, Z. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1160 · Cited by 46
Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration
László, J., Lucas, V. S., Hanson, D., Cronin, C. M., & Sallan, S. E. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02573.x · Cited by 44
Rubovitch, V., Gafni, M., & Sarne, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.012 · Cited by 43
Ahn, K. H., Pellegrini, M., Tsomaia, N., Yatawara, A. K., Kendall, D. A., & Mierke, D. F. (2009) · Biopolymers · doi:10.1002/bip.21179 · Cited by 36
Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol
Borgkvist, A., Marcellino, D. J., Fuxé, K., Greengard, P., & Fisone, G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.025 · Cited by 35
Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders
Beardsley, P. M., Thomas, B. F., & McMahon, L. R. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782786 · Cited by 35
Mu, J., Zhuang, S.-Y., Hampson, R. E., & Deadwyler, S. A. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050975 · Cited by 33
Korzh, A., Keren, O., Gafni, M., Bar-Josef, H., & Sarne, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.070 · Cited by 33
Attenuated behavioural responses to acute and chronic cocaine in GASP‐1‐deficient mice
Boeuf, J., Trigo, J. M., Moreau, P., Lecourtier, L., Vogel, E., Cassel, J., Mathis, C., Klosen, P., Maldonado, R. J., & Simonin, F. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06865.x · Cited by 33
G Protein Coupled Receptors as Drug Targets: The Role of β-Arrestins
Dromey, J. R., & Pfleger, K. D. G. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008783928352 · Cited by 32
Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
Clark, A., Lynch, M., Ware, M., Beaulieu, P., McGilveray, I., & Gourlay, D. (2005) · Pain Research and Management · doi:10.1155/2005/894781 · Cited by 31
Pleiotropic Effects of Rimonabant: Clinical Implications
Després, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315666 · Cited by 28
Cannabinoid modulation of perivascular sympathetic and sensory neurotransmission.
Ralevic, V., & Kendall, D. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787354114 · Cited by 24 · cited 1×
“The interest in metabolic syndrome led to the expansion of studies of CB1 receptors on vascular as well as cardiac tissue [28] [29,30].”
BackgroundGrace, C. R., Cowsik, S. M., Shim, J., et al. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.04.004 · Cited by 18
Zhou, D., & Song, Z. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03091-0 · Cited by 18
Role of Cannabinoid Receptors in Bone Disorders: Alternatives for Treatment
Idris, A. I. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.10.1314055 · Cited by 11
Cited by
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 415
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Self-citationCannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Galve-Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 283
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2409-8 · Cited by 253
Metadata
- Authors
- Howlett, A., Blume, L., & Dalton, G.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-05-01
- Volume
- 17
- Issue
- 14
- Pages
- 1382-1393
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2161344628
- Cited by
- 295
- References
- 149
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.